Rimas J. Orentas, PhD, is Senior Scientific Director, R&D Immunotherapy, in Miltenyi Biotec, Inc. He leads groups focused on CAR-T cells, NK-CARs, gd T-cell and HSC-engineering in Gaithersburg, Maryland, USA and Bergisch-Gladbach, Germany. Dr. Orentas also holds an adjunct professorship in the Johns Hopkins Bloomberg School of Public Health. He is co-founder of Caring Cross, a non-profit implementing low-cost approaches to engineered cell therapies. He has led teams that delivered 6 first-in-human CAR-T products. Previous positions include Professor of Pediatrics, University of Washington School of Medicine, Director of the Ben Towne Center for Childhood Cancer Research (Seattle Children’s Research Institute); Scientific Director of Lentigen, a Miltenyi Biotec Company; Associate Scientist, Pediatric Oncology Branch, NCI, NIH, and faculty positions at the Medical College of Wisconsin.